Barclays’s Harte-Hanks HHS Stock Holding History
Bought
Maintained
Sold
Other funds holding HHS
WCM
KF
RA
BCM
Barclays's HHS Position: Q4 2025 in Review
Barclays sold out of Harte-Hanks (HHS) in Q4 2025, closing a stake of 87 shares — an estimated $323 sold.
Barclays first reported a position in HHS in Q2 2013 and held it in 24 quarters. The position peaked at $421K in Q2 2013. 23 funds tracked by Wall St. Rank hold HHS as of Q4 2025.
- Barclays reported no remaining Harte-Hanks position as of Q4 2025 after selling out during the quarter.
- Barclays sold 87 Harte-Hanks shares in Q4 2025, an estimated $323.
- Barclays first reported a position in Harte-Hanks in Q2 2013 and held it in 24 quarters.
- Barclays's Harte-Hanks position peaked at $421K in Q2 2013.
- 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2025.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.